Literature DB >> 11853560

Evidence for the direct interaction between calmodulin and the human epidermal growth factor receptor.

Hongbing Li1, Antonio Villalobo.   

Abstract

Previous work from our laboratory has demonstrated that the Ca(2+)-calmodulin complex inhibits the intrinsic tyrosine kinase activity of the epidermal growth factor receptor (EGFR), and that the receptor can be isolated by Ca(2+)-dependent calmodulin-affinity chromatography [San José, Bengurija, Geller and Villalobo (1992) J. Biol. Chem. 267, 15237-15245]. Moreover, we have demonstrated that the cytosolic juxtamembrane region of the human receptor (residues 645-660) binds calmodulin in a Ca(2+)-dependent manner when this segment forms part of a recombinant fusion protein [Martijn-Nieto and Villalobo (1998) Biochemistry 37, 227-236]. However, demonstration of the direct interaction between calmodulin and the whole receptor has remained elusive. In this work, we show that calmodulin, in the presence of Ca(2+), forms part of a high-molecular-mass complex built upon covalent cross-linkage of the human EGFR immunoprecipitated from two cell lines overexpressing this receptor. Although several calmodulin-binding proteins co-immunoprecipitated with the EGFR, suggesting that they interact with the receptor, we demonstrated using overlay techniques that biotinylated calmodulin binds directly to the receptor in a Ca(2+)-dependent manner without the mediation of any adaptor calmodulin-binding protein. Calmodulin binds to the EGFR with an apparent dissociation constant (K'(d)) of approx. 0.2-0.3 microM. Treatment of cells with epidermal growth factor, or with inhibitors of protein kinase C and calmodulin-dependent protein kinase II, or treatment of the immunoprecipitated receptor with alkaline phosphatase, does not significantly affect the binding of biotinylated calmodulin to the receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853560      PMCID: PMC1222412          DOI: 10.1042/bj3620499

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation.

Authors:  J L Countaway; P McQuilkin; N Gironès; R J Davis
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

3.  A rapid and sensitive method for detection and quantification of calcineurin and calmodulin-binding proteins using biotinylated calmodulin.

Authors:  M L Billingsley; K R Pennypacker; C G Hoover; D J Brigati; R L Kincaid
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  The EGF receptor as central transducer of heterologous signalling systems.

Authors:  E Zwick; P O Hackel; N Prenzel; A Ullrich
Journal:  Trends Pharmacol Sci       Date:  1999-10       Impact factor: 14.819

6.  Ca2+/calmodulin-dependent kinase II phosphorylates the epidermal growth factor receptor on multiple sites in the cytoplasmic tail and serine 744 within the kinase domain to regulate signal generation.

Authors:  R L Feinmesser; S J Wicks; C J Taverner; A Chantry
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

7.  Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.

Authors:  M R Holbrook; L L Slakey; D J Gross
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

8.  Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

9.  Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor.

Authors:  E Livneh; T J Dull; E Berent; R Prywes; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

10.  Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane.

Authors:  T Hunter; N Ling; J A Cooper
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

View more
  7 in total

1.  Calmodulin binds HER2 and modulates HER2 signaling.

Authors:  Colin D White; Zhigang Li; David B Sacks
Journal:  Biochim Biophys Acta       Date:  2010-12-24

2.  Regulation of the ligand-dependent activation of the epidermal growth factor receptor by calmodulin.

Authors:  Hongbing Li; Svetlana Panina; Amandeep Kaur; María J Ruano; Pablo Sánchez-González; Jonas M la Cour; Alexander Stephan; Uffe H Olesen; Martin W Berchtold; Antonio Villalobo
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

3.  KCNE4 juxtamembrane region is required for interaction with calmodulin and for functional suppression of KCNQ1.

Authors:  Erin J Ciampa; Richard C Welch; Carlos G Vanoye; Alfred L George
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

4.  The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein.

Authors:  Hongbing Li; Juan Sánchez-Torres; Alan Del Carpio; Valentina Salas; Antonio Villalobo
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

5.  Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion.

Authors:  Michael P Sanderson; Sascha Keller; Angel Alonso; Svenja Riedle; Peter J Dempsey; Peter Altevogt
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

6.  Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression.

Authors:  Matthew R Hart; Hsin-Yuan Su; Derrick Broka; Aarthi Goverdhan; Joyce A Schroeder
Journal:  Mol Ther       Date:  2013-10-01       Impact factor: 11.454

7.  Grb7-derived calmodulin-binding peptides inhibit proliferation, migration and invasiveness of tumor cells while they enhance attachment to the substrate.

Authors:  Juan Alcalde; María González-Muñoz; Antonio Villalobo
Journal:  Heliyon       Date:  2020-05-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.